Variation at the ADAM10 gene locus is not associated with Creutzfeldt-Jakob disease

Neuroscience Letters

Volumn 344, Issue 2, 2003, Pages 132-134

  Plamont, Marie Aude ^a,b   Chasseigneaux, Stéphanie ^a,b   Delasnerie Lauprêtre, Nicole ^c   Beaudry, Patrice ^d   Peoc'h, Katell ^a,b   Laplanche, Jean Louis ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

ADAM10; Alzheimer; Creutzfeldt Jakob; Neurologic disorder; Prion; Single nucleotide polymorphism

Indexed keywords

PRION PROTEIN; PROTEIN; PROTEIN ADAM 10; UNCLASSIFIED DRUG;

ADULT; AGED; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC PARAMETERS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0037680698     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00364-1     Document Type: Short Survey

References (20)

1. Amour A., Knight C.G., Webster A., Slocombe P.M., Stephens P.E., Knauper V., Docherty A.J., Murphy G. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473:2000;275-279.
2. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., Bostock C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 389:1997;498-501.
3. Chabry J., Caughey B., Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J. Biol. Chem. 273:1998;13203-13207.
4. Checler F., Vincent B. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 25:2002;616-620.
5. Chen S.G., Teplow D.B., Parchi P., Teller J.K., Gambetti P., Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270:1995;19173-19180.
6. Cosseddu G.M., Oustry-Vaiman A., Jego B., Moreno C., Taourit S., Cribiu E.P., Elsen J.M., Vaiman D. Sheep/human comparative map in a chromosome region involved in scrapie incubation time shows multiple breakpoints between human chromosomes 14 and 15 and sheep chromosomes 7 and 18. Chromosome Res. 10:2002;369-378.
7. c delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J. Virol. 72:1998;1153-1159.
8. Kovacs G.G., Trabattoni G., Hainfellner J.A., Ironside J.W., Knight R.S., Budka H. Mutations of the prion protein gene phenotypic spectrum. J. Neurol. 249:2002;1567-1582.
9. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA. 96:1999;3922-3927.
10. Laplanche J.L., Delasnerie-Lauprêtre N., Brandel J.P., Chatelain J., Beaudry P., Alperovitch A., Launay J.M. Molecular genetics of prion diseases in France. Neurology. 44:1994;2347-2351.
11. Lloyd S.E., Uphill J.B., Targonski P.V., Fisher E.M., Collinge J. Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice. Neurogenetics. 4:2002;77-81.
12. Manolakou K., Beaton J., McConnell I., Farquar C., Manson J., Hastie N.D., Bruce M., Jackson I.J. Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc. Natl. Acad. Sci. USA. 19:2001;7402-7407.
13. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., Kellermann O. Signal transduction through prion protein. Science. 289:2000;1925-1928.
14. Palmer M.S., Dryden A.J., Hughes J.T., Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 352:1991;340-342.
15. Primakoff P., Myles D. The ADAM gene family, surface proteins with adhesion and protease activity. Trends Genet. 16:2000;83-87.
16. Prusiner S.B. Shattuck lecture - neurodegenerative diseases and prions. N. Engl. J. Med. 344:2001;1516-1526.
17. Rachidi W., Vilette D., Guiraud P., Arlotto M., Riondel J., Laude H., Lehmann S., Favier A. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278:2003;9064-9072.
18. Stephenson D.A., Chiotti K., Ebeling C., Groth D., DeArmond S.J., Prusiner S.B., Carlson G.A. Quantitative trait loci affecting prion incubation time in mice. Genomics. 69:2000;47-53.
19. Van Rheede T., Smolenaars M.M., Madsen O., De Jong W.W. Molecular evolution of the mammalian prion protein. Mol. Biol. Evol. 20:2003;111-121.
20. Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D., De Strooper B., Grassi J., Lopez-Perez E., Checler F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276:2001;37743-37746.